The management of HIV/cancer co-infection presents a significant clinical challenge due to the complex interplay between these two diseases. Traditional treatment approaches often fall short in effectively addressing both infections simultaneously. Consequently, there is an urgent need for advanced therapeutic strategies. Novel drug combinations a

Cytomegalovirus (CMV), a prevalent herpesvirus, commonly infects humans globally. Though generally asymptomatic, CMV can pose serious health risks to vulnerable individuals, such as those with HIV/AIDS or undergoing organ transplantation.{Infection occurs through saliva, blood, urine, and other bodily fluids. Symptoms of CMV infection can range fro